famotidine, calcium carbonate, magnesium hydroxide chewable tablet
PEPCID COMPLETE (famotidine, calcium carbonate, magnesium hydroxide chewable tablet) is histamine h2 receptor antagonists [moa]. First approved in 2000.
Drug data last refreshed 12h ago · AI intelligence enriched 3w ago
Pepcid Complete is a combination chewable tablet containing famotidine (an H2-receptor antagonist), calcium carbonate, and magnesium hydroxide for oral use. It treats heartburn, acid indigestion, and sour stomach by reducing stomach acid production while providing immediate antacid relief. The famotidine component blocks histamine-2 receptors to decrease acid secretion, while the antacids neutralize existing acid.
As an OTC product approaching loss of exclusivity with moderate competitive pressure (30), brand teams face contraction with focus shifting toward cost management and defensive positioning rather than growth.
Histamine H2 Receptor Antagonists
Histamine-2 Receptor Antagonist
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Pepcid Complete offers limited career growth potential given the product's LOE-approaching status and lack of linked job postings. Roles are primarily defensive and cost-focused, with emphasis on generic transition planning and market-share retention rather than innovation or expansion.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo